Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
An international team of scientists are to set to use thousands of MRI brain scans from research teams around the world in a bid to study Neurofibromatosis Type 1 (NF1), a lifelong neurological condition.
Continue reading full article: Brain scans to give crucial insight into childhood genetic disease
Manchester researchers are part of an international team aiming to advance risk prediction, early detection of disease progression and personalised prevention in rheumatoid arthritis and inflammatory bowel disease to improve patient outcomes.
Continue reading full article: New project “PerPrev-CID” investigates innovative approaches for personalised prevention and early treatment of chronic inflammatory diseases
Almost half of all UK adults regularly take prescription medicines and the annual NHS budget for medicines is approximately £17.4 billion per year, with over 1.1 billion items prescribed annually.
Continue reading full article: Advancing the application of pharmacogenomics via digital innovation; introducing ProgressRX
A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care.
Continue reading full article: Biomarker test could significantly reduce antibiotic use in sepsis, finds trial
Greater Manchester residents are being encouraged to take part in a research study at Manchester Royal Eye Hospital (MREH) that aims to improve the diagnosis and treatment of conditions associated with sight loss.
Continue reading full article: Local MP takes part in Manchester-led genetic eye research
Recently the NIHR BRC and the NIHR North West Regional Research Delivery Network collaboratively hosted the Greater Manchester Inflammation Showcase: Musculoskeletal Diseases (MSK) and Dermatology Focus event at CityLabs 1.0.
Continue reading full article: Showcasing pioneering inflammation research in Greater Manchester
Research delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
Continue reading full article: Manchester-led research contributes to development of new UK-wide guideline for asthma
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist newborn) units across England, Scotland, Wales and Northern Ireland.
Continue reading full article: Genetic test developed by Manchester researchers to prevent newborn babies going deaf, to be trialled across the UK